Profen and Oruvail drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Profen (ibuprofen) and Oruvail (ketoprofen). Common drug interactions include abdominal pain among females and coma among males.

The phase IV clinical study analyzes what interactions people have when they take Profen and Oruvail. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

What is Oruvail?

Oruvail has active ingredients of ketoprofen. eHealthMe is studying from 648 Oruvail users. Check the latest studies of Oruvail.



On Jul, 12, 2026

24 people who take Profen and Oruvail together, and have interactions are studied.

Profen and Oruvail drug interactions.

What are the common drug interactions of Profen and Oruvail, by gender? *:

female:

  1. Abdominal pain
  2. Cystocele (a condition that occurs when the tough fibrous wall between a woman's bladder and her vagina is torn by childbirth)
  3. Dyspareunia (painful sexual intercourse)
  4. Muscle spasms (muscle contraction)
  5. Pelvic pain
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Pyrexia (fever)
  8. Rectocele (a bulging of the front wall of the rectum into the back wall of the vagina)
  9. Uterine cancer
  10. Acute sinusitis

male:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Confusional state
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Ventricular fibrillation (abnormally irregular heart rhythm)
  5. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  6. Viral infection
  7. Weight increased
  8. Abdominal distension
  9. Agitation (state of anxiety or nervous excitement)
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

What are the common drug interactions of Profen and Oruvail, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Amblyopia (lazy eye)
  2. Cardiovascular disorder (heart diseases)
  3. Chest pain
  4. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  5. Dry mouth
  6. Dyspnoea (difficult or laboured respiration)
  7. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

30-39:

  1. Drug addiction

40-49:

  1. Muscle spasms (muscle contraction)
  2. Osteonecrosis of jaw (death of bone of jaw)
  3. Pelvic pain
  4. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  5. Pyrexia (fever)
  6. Rectocele (a bulging of the front wall of the rectum into the back wall of the vagina)
  7. Uterine cancer
  8. Acute sinusitis
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Cough

50-59:

  1. Breast cancer
  2. Muscle atrophy (a decrease in the mass of the muscle)

60+:

  1. Bone disorder
  2. Asthenia (weakness)
  3. Breast cancer
  4. Breast cancer metastatic
  5. Cardiac failure congestive
  6. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  7. Cervix haemorrhage uterine (bleeding from cervix in birth canal)
  8. Disability
  9. Epicondylitis (tennis elbow)
  10. Fibula fracture

What are the existing conditions these people have? *

  1. Menopausal Symptoms: 2 people, 8.33%
  2. Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 8.33%
  3. High Blood Pressure: 2 people, 8.33%
  4. Anaemia (lack of blood): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and Oruvail?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Profen and Oruvail:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oruvail:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oruvail and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and ketoprofen (the active ingredients of Profen and Oruvail, respectively), and Profen and Oruvail (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: